|
|
|
Volumn 23, Issue 6 SUPPL. 16, 1996, Pages 32-34
|
|
Schedule- and dose-intensified paclitaxel as weekly 1-hour infusion in pretreated solid tumors: Results of a phase I/II trial
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CIMETIDINE;
CLEMASTINE;
DEXAMETHASONE;
ONDANSETRON;
PACLITAXEL;
ADULT;
AGED;
BLOOD TOXICITY;
CANCER COMBINATION CHEMOTHERAPY;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONFERENCE PAPER;
DOSE RESPONSE;
FEMALE;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
MALE;
MAXIMUM PERMISSIBLE DOSE;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
SOLID TUMOR;
TREATMENT OUTCOME;
ADULT;
AGED;
ANTI-ALLERGIC AGENTS;
ANTIEMETICS;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
CIMETIDINE;
CLEMASTINE;
DEXAMETHASONE;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
HISTAMINE H2 ANTAGONISTS;
HUMANS;
INFUSIONS, PARENTERAL;
MALE;
MIDDLE AGED;
NEOPLASMS;
ONDANSETRON;
PACLITAXEL;
|
|
EID: 0030479075
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (54)
|
|
References (4)
|
